We serve Chemical Name:1-N-Boc-belta-Proline CAS:140148-70-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-N-Boc-belta-Proline
CAS.NO:140148-70-5
Synonyms:1-(tert-butoxycarbonyl)pyrrolidine-3-carboxylic acid;(S)-1-(tert-Butoxycarbonyl)pyrrolidine-3-carboxylic acid;1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-3-pyrrolidinecarboxylic acid;1,3-Pyrrolidinedicarboxylic acid, 1-(1,1-dimethylethyl) ester;MFCD03094728;(S)-1-Boc-3-pyrrolidinecarboxylic acid;1-Boc-pyrrolidine-3-carboxylic acid;(S)-1-Boc-Pyrrolidine-3-carboxylic acid;S-1-Boc-3-pyrrolidinecarboxylic acid;N-Boc-L-beta-proline;1-N-Boc-belta-Proline
Molecular Formula:C10H17NO4
Molecular Weight:215.246
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:337.2±35.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.503
PSA:66.84000
Exact Mass:215.115753
LogP:0.65
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077 9 / PGIII
Packing Group:
Contact us for information like 1-(tert-butoxycarbonyl)pyrrolidine-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-N-Boc-belta-Proline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-3-pyrrolidinecarboxylic acid Use and application,(S)-1-(tert-Butoxycarbonyl)pyrrolidine-3-carboxylic acid technical grade,usp/ep/jp grade.
Related News: Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity. 1-N-Boc-belta-Proline manufacturer Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity. 1-N-Boc-belta-Proline supplier Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity. 1-N-Boc-belta-Proline vendor The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 1-N-Boc-belta-Proline factory The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 1-N-Boc-belta-Proline factory The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.
